iodixanol has been researched along with Hepatitis C in 1 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vercauteren, K | 1 |
| Van Den Eede, N | 1 |
| Mesalam, AA | 1 |
| Belouzard, S | 1 |
| Catanese, MT | 1 |
| Bankwitz, D | 1 |
| Wong-Staal, F | 1 |
| Cortese, R | 1 |
| Dubuisson, J | 1 |
| Rice, CM | 1 |
| Pietschmann, T | 1 |
| Leroux-Roels, G | 1 |
| Nicosia, A | 1 |
| Meuleman, P | 1 |
1 other study available for iodixanol and Hepatitis C
| Article | Year |
|---|---|
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Lipoproteins; M | 2014 |